Plain-English translation of NCT06968962 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two different ways of treating pulmonary arterial hypertension — a serious condition where blood vessels in the lungs become narrowed and stiff. One group will start taking and together immediately, while other groups will start with just one medication and add the second one later if their condition doesn't improve enough. The goal is to figure out which approach works better and helps people exercise longer.
Right now, doctors aren't sure whether it's better to give patients two medications from the start or to begin with one and add more as needed. This trial will help determine which strategy leads to better outcomes and helps people feel stronger and more active.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of three groups. One group starts taking both medications together right away, while the other two groups start with just one medication and may have the second added at 4, 8, or 12 months if needed. You'll visit the clinic every 4 months for 12 months for check-ups, walk tests, and heart assessments. Neither you nor your doctor will know which specific medications you're taking (the study is 'blinded' for safety and fairness), and your treatment may be adjusted based on how you're doing.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China